Incidence and Predictors of Opioid Overdose and Death Among Long-Term Users of Opioid Analgesics

Completed

Conditions studied: Opioid Overdose

In brief

Retrospective study to assess incidence and predictors of opioid abuse overdose and death associated with opioid overdose among patients prescribed opioid products in long-term use.

Key facts

Study ID

NCT02662153

Run by

Member Companies of the Opioid PMR Consortium

People needed

808455

Starts

2019-05-02

Expected to finish

2021-06-30

Last updated by the study team

2022-07-14

Who can join

Age: 18 and older, up to 79. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• In the primary analysis, persons known to have had at least six months of no opioid dispensing who subsequently receive at least 70 days of Schedule II opioid dispensed within a 90-day period and who have not previously experienced an opioid overdose.
• In a secondary analysis, persons who have been long-term users of IR/SA opioids and who switch to a different Schedule II IR/SA opioid product or to an ER/LA opioid
• In another secondary analysis, persons with at least six months of presence in the health insurance data who have not received opioids in the preceding 30 days, and have not previously experienced an opioid overdose

You may not qualify if…

• Experience of opioid overdose in the six months preceding inclusion

Where it is running

• HealthCore Inc — Wilmington, Delaware, United States
• Optum — Boston, Massachusetts, United States
• Kaiser Permanente Northwest — Portland, Oregon, United States
• Vanderbilt University — Nashville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.